AC
CANO

Armistice Capital’s Cano Health, Inc. CANO Stock Holding History

Armistice Capital’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,720
Closed -$3.66M – 263
2022
Q4 		$3.66M Buy
+26,720
New +$9.05M 0.06% 107

Other funds holding CANO

DCP
Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital's CANO Position: Q1 2023 in Review

Armistice Capital sold out of Cano Health, Inc. (CANO) in Q1 2023, closing a stake of 26,720 shares — an estimated $3.66M sold.

Armistice Capital first reported a position in CANO in Q4 2022 and held it in 1 quarter. The position peaked at $3.66M in Q4 2022. 163 funds tracked by Wall St. Rank hold CANO as of Q1 2023.

  • Armistice Capital reported no remaining Cano Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Armistice Capital sold 26,720 Cano Health, Inc. shares in Q1 2023, an estimated $3.66M.
  • Armistice Capital first reported a position in Cano Health, Inc. in Q4 2022 and held it in 1 quarter.
  • Armistice Capital's Cano Health, Inc. position peaked at $3.66M in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2023.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.